Business Wire

Bio-Rad Announces Closing of $1.2 Billion Aggregate Senior Notes Offering

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, announced today the closing of its ...
The Caledonian-Record

Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes

Gossamer Bio, Inc. (NASDAQ: GOSS) (the “Company” or “Gossamer”), a biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial ...
Nasdaq

BridgeBio Pharma Announces $500 Million Convertible Senior Notes Offering to Strengthen Balance Sheet and Enhance Financial Flexibility

BridgeBio Pharma plans to offer $500 million in convertible senior notes, aiming to strengthen its financial position and reduce interest expenses. BridgeBio Pharma, Inc. announced plans to offer $500 ...
Nasdaq

BridgeBio Pharma, Inc. Prices $500 Million Convertible Senior Notes Offering to Lower Debt and Enhance Financial Flexibility

BridgeBio Pharma, Inc. has announced the pricing of $500 million in convertible senior notes at a 1.75% interest rate, maturing in 2031, in a private offering aimed at qualified institutional buyers.